These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 35354034)

  • 1. Ligand-independent oligomerization of TACI is controlled by the transmembrane domain and regulates proliferation of activated B cells.
    Smulski CR; Zhang L; Burek M; Teixidó Rubio A; Briem JS; Sica MP; Sevdali E; Vigolo M; Willen L; Odermatt P; Istanbullu D; Herr S; Cavallari M; Hess H; Rizzi M; Eibel H; Schneider P
    Cell Rep; 2022 Mar; 38(13):110583. PubMed ID: 35354034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The murine equivalent of the A181E TACI mutation associated with common variable immunodeficiency severely impairs B-cell function.
    Lee JJ; Rauter I; Garibyan L; Ozcan E; Sannikova T; Dillon SR; Cruz AC; Siegel RM; Bram R; Jabara H; Geha RS
    Blood; 2009 Sep; 114(11):2254-62. PubMed ID: 19605846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transmembrane activator and calcium-modulator and cyclophilin ligand interactor mutations in common variable immunodeficiency.
    Lee JJ; Ozcan E; Rauter I; Geha RS
    Curr Opin Allergy Clin Immunol; 2008 Dec; 8(6):520-6. PubMed ID: 18978466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TACI mutations and impaired B-cell function in subjects with CVID and healthy heterozygotes.
    Martinez-Gallo M; Radigan L; Almejún MB; Martínez-Pomar N; Matamoros N; Cunningham-Rundles C
    J Allergy Clin Immunol; 2013 Feb; 131(2):468-76. PubMed ID: 23237420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced BAFF-R and increased TACI expression in common variable immunodeficiency.
    Barbosa RR; Silva SL; Silva SP; Melo AC; Pereira-Santos MC; Barata JT; Hammarström L; Cascalho M; Sousa AE
    J Clin Immunol; 2014 Jul; 34(5):573-83. PubMed ID: 24809296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TACI, isotype switching, CVID and IgAD.
    Castigli E; Geha RS
    Immunol Res; 2007; 38(1-3):102-11. PubMed ID: 17917015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TNF receptor superfamily member 13b (TNFRSF13B) hemizygosity reveals transmembrane activator and CAML interactor haploinsufficiency at later stages of B-cell development.
    Romberg N; Virdee M; Chamberlain N; Oe T; Schickel JN; Perkins T; Cantaert T; Rachid R; Rosengren S; Palazzo R; Geha R; Cunningham-Rundles C; Meffre E
    J Allergy Clin Immunol; 2015 Nov; 136(5):1315-25. PubMed ID: 26100089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transmembrane activator and calcium-modulating cyclophilin ligand interactor mutations in common variable immunodeficiency: clinical and immunologic outcomes in heterozygotes.
    Zhang L; Radigan L; Salzer U; Behrens TW; Grimbacher B; Diaz G; Bussel J; Cunningham-Rundles C
    J Allergy Clin Immunol; 2007 Nov; 120(5):1178-85. PubMed ID: 17983875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel mutations in TACI (TNFRSF13B) causing common variable immunodeficiency.
    Mohammadi J; Liu C; Aghamohammadi A; Bergbreiter A; Du L; Lu J; Rezaei N; Amirzargar AA; Moin M; Salzer U; Pan-Hammarström Q; Hammarström L
    J Clin Immunol; 2009 Nov; 29(6):777-85. PubMed ID: 19629655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of TACI signaling on humoral immunity and autoimmune diseases.
    Zhang Y; Li J; Zhang YM; Zhang XM; Tao J
    J Immunol Res; 2015; 2015():247426. PubMed ID: 25866827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dominant-negative effect of the heterozygous C104R TACI mutation in common variable immunodeficiency (CVID).
    Garibyan L; Lobito AA; Siegel RM; Call ME; Wucherpfennig KW; Geha RS
    J Clin Invest; 2007 Jun; 117(6):1550-7. PubMed ID: 17492055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The C104R mutant impairs the function of transmembrane activator and calcium modulator and cyclophilin ligand interactor (TACI) through haploinsufficiency.
    Lee JJ; Jabara HH; Garibyan L; Rauter I; Sannikova T; Dillon SR; Bram R; Geha RS
    J Allergy Clin Immunol; 2010 Dec; 126(6):1234-41.e2. PubMed ID: 20889194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TACI, unlike BAFF-R, is solely activated by oligomeric BAFF and APRIL to support survival of activated B cells and plasmablasts.
    Bossen C; Cachero TG; Tardivel A; Ingold K; Willen L; Dobles M; Scott ML; Maquelin A; Belnoue E; Siegrist CA; Chevrier S; Acha-Orbea H; Leung H; Mackay F; Tschopp J; Schneider P
    Blood; 2008 Feb; 111(3):1004-12. PubMed ID: 17942754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypic and clinical heterogeneity associated with monoallelic TNFRSF13B-A181E mutations in common variable immunodeficiency.
    Dong X; Hoeltzle MV; Hagan JB; Park MA; Li JT; Abraham RS
    Hum Immunol; 2010 May; 71(5):505-11. PubMed ID: 20156508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transmembrane activator, calcium modulator, and cyclophilin ligand interactor drives plasma cell differentiation in LPS-activated B cells.
    Ozcan E; Garibyan L; Lee JJ; Bram RJ; Lam KP; Geha RS
    J Allergy Clin Immunol; 2009 Jun; 123(6):1277-86.e5. PubMed ID: 19427685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Naturally occurring mutation affecting the MyD88-binding site of TNFRSF13B impairs triggering of class switch recombination.
    Almejun MB; Cols M; Zelazko M; Oleastro M; Cerutti A; Oppezzo P; Cunningham-Rundles C; Danielian S
    Eur J Immunol; 2013 Mar; 43(3):805-14. PubMed ID: 23225259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetics of common variable immunodeficiency: role of transmembrane activator and calcium modulator and cyclophilin ligand interactor.
    Sathkumara HD; De Silva NR; Handunnetti S; De Silva AD
    Int J Immunogenet; 2015 Aug; 42(4):239-53. PubMed ID: 26096648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Common variable immunodeficiency: two mutations are better than one.
    La Cava A
    J Clin Invest; 2013 Oct; 123(10):4142-3. PubMed ID: 24051372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three different classifications, B lymphocyte subpopulations, TNFRSF13B (TACI), TNFRSF13C (BAFF-R), TNFSF13 (APRIL) gene mutations, CTLA-4 and ICOS gene polymorphisms in Turkish patients with common variable immunodeficiency.
    Kutukculer N; Gulez N; Karaca NE; Aksu G; Berdeli A
    J Clin Immunol; 2012 Dec; 32(6):1165-79. PubMed ID: 22699762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of TACI mutations in CVID & RESPI patients who have inherited HLA B*44 or HLA*B8.
    Waldrep ML; Zhuang Y; Schroeder HW
    BMC Med Genet; 2009 Sep; 10():100. PubMed ID: 19775471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.